Artificial intelligence: The role for research and patient treatment

Artificial intelligence (AI) is not only a futuristic vision but is becoming increasingly relevant in treatment decision and experimental research.

Published Wed, 2 Mar 2022
E CourseOncologyBladder CancerProstate CancerKidney CancerArtificial IntelligenceESUREAU Section Of Urological Research
Organiser European School of Urology (ESU)
CME 1.0
Duration Approx. 70 minutes

The complex analysis of clinical, histopathological, and biomarker data allows precise diagnosis and prognostic evaluation, and therefore can help realise individualised treatment.

In addition, the management of big data obtained through experimental research to understand complex biological processes of diseases (especially in cancer research) is impossible without AI analytical tools.

This UROwebinar gives insights in AI instruments in uro-oncology, and discusses the advantages and limitations

Moderator and presenter: Prof. H.Y. Leung (GB), Prof. Dr. G. Cacciamani (US), Prof. C. Jeronimo (PT)
Fellow presenters: Dr. G. Litjens (NL) and Prof. E. Van Allen (US)

Contact our organiser

European School of Urology (ESU)